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Antiviral cell–mediated immunity is initiated by the dendritic cell (DC) network in lymph 
nodes (LNs). Plasmacytoid DCs (pDCs) are known to migrate to inflamed LNs and produce 
interferon (IFN)-
 
 
 
, but their other roles in antiviral T cell immunity are unclear. We report 
that LN-recruited pDCs are activated to create local immune fields that generate antiviral 
cytotoxic T lymphocytes (CTLs) in association with LNDCs, in a model of cutaneous herpes 
simplex virus (HSV) infection. Although pDCs alone failed to induce CTLs, in vivo depletion 
of pDCs impaired CTL-mediated virus eradication. LNDCs from pDC-depleted mice showed 
impaired cluster formation with T cells and antigen presentation to prime CTLs. Transferring 
circulating pDC precursors from wild-type, but not CXCR3-deficient, mice to pDC-depleted 
mice restored CTL induction by impaired LNDCs. In vitro co-culture experiments revealed 
that pDCs provided help signals that recovered impaired LNDCs in a CD2- and CD40L-
dependent manner. pDC-derived IFN-
 
 
 
 further stimulated the recovered LNDCs to induce 
CTLs. Therefore, the help provided by pDCs for LNDCs in primary immune responses seems to 
be pivotal to optimally inducing anti-HSV CTLs.
 
Viruses have evolved a variety of mechanisms
to evade the immune system, invade host tissues,
and, sometimes, establish persistent infections
(1). One strategy by which hosts counter these
assaults is the rapid response of the DC net-
work to eliminate virally infected cells. In
mice, there are at least three major func-
tional subtypes of DCs in LNs: myeloid DCs
(mDCs; CD11b
 
 
 
B220
 
–
 
CD11c
 
 
 
), CD8
 
 
 
 
 
DCs (CD8
 
 
 
 
 
B220
 
–
 
CD11c
 
 
 
), and plasmacy-
toid DCs (pDCs; B220
 
 
 
CD11c
 
 
 
), which induce
distinct types of antiviral T lymphocytes (2, 3).
This heterogeneity in the DC network allows
flexibility in the immune response, depending
on the tissue environment and exogenous factors
in LNs (2, 4). In HSV-2 infections of the vaginal
submucosa, newly recruited mDCs induce virus-
specific T helper cells (5), whereas in cutane-
ous HSV-1 infections, CD8
 
 
 
 
 
 DCs, which
mainly reside in LNs, are responsible for cross-
priming antiviral CTLs (6). In contrast, pDCs
function poorly as APCs for naive T cells, but
produce large amounts of antiviral IFN-
 
 
 
.
However, the contribution of pDCs to antiviral
immunity in vivo remains controversial, as
they have been reported to promote a variety
of immune responses in vitro (3, 7).
Recent investigations have revealed that
tissue-resident mDCs and pDCs in a normal,
infection-free animal maintain peripheral tol-
erance (7, 8). In response to inflammation, these
DCs are activated to induce T cell–mediated
immunity, but the mechanism by which the
DC system is converted from “tolerogenic” to
“immunogenic” remains controversial (3, 8).
We are particularly interested in the role of in-
flammation-associated circulating DC precursors
in this conversion (9–11). In a cutaneous
HSV-1 infection model, we recently demon-
strated that large
 
 
 
numbers of both mDC and
pDC precursors appear de novo in the circula-
tion in response to TNF-
 
 
 
 (10). mDC precur-
sors are preferentially recruited to sites of in-
flammation and remobilized into draining
LNs, where they act as APCs (9, 10). In con-
trast, pDC precursors directly enter the LNs
through activated high endothelial venules
(HEVs) in a CXCL9- and E-selectin–dependent
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manner (10). This inflammation-dependent, CXCR3-driven
trafficking pathway is distinct from that used by mDCs, but
similar to that used by monocytes (12) and NK cells (13).
This suggests that LN-recruited pDCs and mDCs have dis-
tinct functions, but the fate of pDCs after entering the LNs
has not been established in vivo.
We have studied the contribution of LN-recruited pDCs
to anti-HSV CTL-mediated immunity and have shown that
they are associated with LNDCs as well as 5
 
 
 
-bromo-2
 
 
 
-deoxy-
uridine
 
 (
 
BrdU)–positive T cells in vivo, but act as poor APCs
for IFN-
 
 
 
 
 
 CTLs. In vivo depletion of LN pDCs using
three distinct methods and in vivo reconstitution assays using
freshly isolated pDC precursors showed that LN-recruited
pDCs are able to convert virally impaired LNDC networks
into completely activated ones that are able to induce anti-
HSV CTLs. Although the DC–virus interplay is dependent
on the type and dose of virus, this study provides novel in-
sights into the role of pDCs in antiviral CTL immunity.
 
RESULTS
Recruitment and activation of pDCs in inflamed LNs
 
We have traced the fate of pDCs (B220
 
 
 
CD11c
 
 
 
CD3
 
 
 
–
CD19
 
 
 
DX5
 
 
 
) in draining popliteal LNs (PLNs) after infecting
mice with HSV-1 in the right footpad. The frequency and
number of PLN pDCs peaked on day 2 and decreased thereaf-
ter (Fig. 1 A). The increase of PLN pDCs was largely caused by
accelerated recruitment of pDC precursors directly from the
circulation, as previously reported (10). Although blood pDC
precursors (MHCII
 
 
 
B220
 
 
 
CD11c
 
 
 
CD3
 
 
 
CD19
 
 
 
DX5
 
 
 
) did
not express CD86, CD40, and CD40 ligand (CD40L) on day 2
(Fig. 1 B), the expression of these activation markers was up-
regulated on PLN pDCs on day 2 (Fig. 1 C). PLN pDCs iso-
lated on day 2 and restimulated in vitro with irradiated HSV
produced high levels of IFN-
 
 
 
, but uninfected PLN pDCs and
blood pDC precursors did not (Fig. 1 D). These results sug-
gested that pDCs were activated after entering the draining LNs
and produced cytokines on encountering HSV-1.
 
Recruited pDCs contact physically with LNDCs
 
Before infection, only small numbers of pDCs were found in
the paracortex, a T cell zone of PLNs (Fig. 2 A). However, a
new influx of pDCs appeared in the paracortex on day 2 and
colocalized with B220
 
 
 
 LNDCs (mDCs and CD8
 
 
 
 
 
 DCs; Fig.
2 B). To determine whether pDCs were attracted by LNDCs
after entering LNs, we adoptively transferred carboxyfluorescein
succinimidyl ester (CFSE)–labeled pDC precursors i.v. into
HSV-infected mice on day 2. By 2 h, the transferred pDC pre-
cursors were in close contact with LNDCs in the paracortex,
and some were associated with pDCs in the perifollicular zone
(Fig. 2 C). 48 h later, transferred pDC precursors were still re-
tained in these zones around HEVs (Fig. 2 D). The transferred
pDCs did not always attach to CCL21
 
 
 
 stromal cells (Fig. 2 D),
suggesting that other chemokines derived from LNDCs or
pDCs might preferentially attract pDCs. Because LNDC-
derived CXCL10 mediates DC–T cell interactions in inflamed
LNs (14), the CXCL10–CXCR3 pathway must play an impor-
tant role in inflammatory conditions. PLN pDCs on day 2 ex-
pressed high levels of CXCL10 (Fig. 2 E), which is known to
attract Th1 precursor cells (14), as well as pDCs themselves (10).
Blood pDC precursors constitutively express high levels
of adhesion molecules, including VLA-4/
 
 
 
4-integrin (97%)
and CD11a/LFA-1 (99%; reference 10), but low levels of
CD2/LFA-2. However, CD2 was up-regulated on day 2,
but only on PLN pDCs (Fig. 2 F), indicating that activated
Figure 1. Recruitment and activation of pDCs in inflamed LNs. 
(A) The frequency (top) and the absolute numbers (bottom) of B220 CD11c  
pDCs in PLNs (rt. PLN) from uninfected (d0) or HSV-infected mice on day 2 
(d2). (B) Expression of CD86, CD40, and CD40L on blood pDC precursors 
from uninfected (d0) or HSV-infected mice on day 2 (d2). (C) Expression of 
CD86, CD40, and CD40L on LN CD11c  DCs from uninfected (d0) or HSV-
infected mice on day 2 (d2). The percentages of cells are indicated. (D) IFN-  
production by sorted pDC precursors from HSV-infected mice on day 2 
(pDCpre) and PLN pDCs from uninfected (LN pDC d0) or HSV-infected 
mice on day 2 (LN pDC d2) after 16 h of incubation with irradiated HSV. 
(A and D) Representative values from three independent experiments are 
presented as the mean   SD (n   6). 
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pDCs up-regulate CD2 and CXCL10 rapidly after entering
the LNs. To understand the mechanism by which recruited
pDCs and LNDCs physically associate, we performed ex vivo
clustering assays using pDCs and LNDCs isolated from PLNs.
After 2 h of incubation at 40 revolutions per minute (rpm),
the number of cluster-forming LNDCs was counted. Strong
conjugates were seen only using DCs isolated from infected
LNs, and CD40L was detected on the boundary (Fig. 2, G
and H). Cell conjugates were significantly inhibited by treat-
ment with anti-CD2 mAb alone or in combination with
anti-CXCL10 mAb (P 
 
 
 
 0.05; Fig. 2 H). This suggested that
LNDC- and pDC-derived CXCL10 attracted pDCs, and
that CXCR3 and CD2 on pDCs mediated their binding.
 
In vivo depletion of LN-recruited pDCs impairs 
CTL-mediated virus eradication
 
To investigate the contribution of LN-recruited pDCs to
anti–HSV-1 CTL immunity, we used three independent ap-
proaches to deplete LN-recruited pDCs in vivo
 
.
 
 We tested
PLN CD8
 
 
 
 T cells on day 7 for CTL precursor frequency,
using an IFN-
 
 
 
 ELISPOT assay, and for CTL function, us-
ing an in vitro cytotoxicity assay against HSV-1–infected
syngeneic splenocytes.
First, CXCR3-driven LN recruitment of pDCs was inhib-
ited by the combined blockade of CXCL9 and E-selectin (10).
A single injection of 100 
 
 
 
g of blocking anti-CXCL9 and anti–
E-selectin antibodies (Abs) on day 0 almost completely blocked
the increase in pDCs, but not LNDCs, in the PLNs (Fig. 3 A).
This was mostly because of the selective inhibition of pDC pre-
cursor transmigration across inflamed LN HEVs (10). Both the
induction of IFN-
 
 
 
 
 
 CTLs and CTL function were detected in
CD8
 
 
 
 T cells isolated from PLNs from control mice, but re-
duced in mice treated with blocking Abs (Fig. 3, B and C).
Control mice were able to eliminate HSV-1 to a significant ex-
tent, but the virus persisted in the anti-CXCL9 and anti–
E-selectin Ab–treated mice (P 
 
 
 
 0.05; Fig. 3 D). Although
these findings showed that the early recruitment (Fig. 3 A) of
pDC precursors into the inflamed LNs was crucial for generat-
ing functional anti–HSV-1 CTLs, we performed further exper-
iments to rule out the possibility that a CXCL9 blockade was
affecting late T cell responses, as well as early pDC effects.
Our second approach used anti-Ly6G/C Ab to deplete
the pDC population without affecting other APCs, B cells,
and macrophages (15). Injecting mice twice with this antibody
depleted 
 
 
 
70% of PLN-resident pDCs (Fig. S1 A, available at
http://www.jem.org/cgi/content/full/jem.20041961/DC1)
Figure 2. Recruited pDCs contact LNDCs in a CXCL10- and CD2-
dependent manner. (A and B) Distribution of B220 CD11c  LNDCs 
(red) and B220 CD11c  pDCs (yellow) in the T cell zones in normal 
(A, d0) and HSV-infected (B, d2) PLN. Arrows indicate contact between 
pDCs and LNDCs on day 2. Bars: (A and B, left) 40  m; (B, right) 20  m. 
(C) CFSE-labeled pDC precursors (green) were adoptively transferred into 
HSV-infected mice on day 2. PLNs 2 h after transfer (d2) are shown. 
CD11c is red and B220 is blue. Transferred pDCs (green/white) are in 
contact with B220 CD11c  LNDCs (bottom right, red) and B220 CD11c  
pDCs (top right, pink). (D) PLNs 48 h after transfer (d4). CCL21 is red and 
B220 is blue. F, follicle; PC, paracortex. Bar, (C and D) 80  m. (E) Relative 
expression levels of CXCL10 by freshly isolated pDC precursors from 
HSV-infected mice on day 2 (pDCpre) and PLN pDCs of uninfected (LN 
pDC d0) or HSV-infected mice on day 2 (LN pDC d2). The housekeeping 
enzyme hypoxanthine phosphoribosyl transferase (HPRT) was used as an 
internal standard. (F) Expression of CD2 on blood pDC precursors and 
PLN pDCs from uninfected (d0) or HSV-infected mice on day 2 (d2). 
(G) CD40L expression (red) on d2 LNDC–pDC conjugates. A CFSEhigh LNDC 
(asterisk) and three CFSElow pDCs are shown. High-contrast image shows 
that CD40L is expressed on the edge of pDCs (bottom right). Bar, 20  m. 
(H) The effect of blocking Abs against CD2 and CD2   CXCL10 on the 
percentage of LNDCs forming clusters, using PLN DCs from uninfected 
(d0) and HSV-infected mice on day 2 (d2). Representative data from 
three independent experiments are presented as the mean   SD (n   6). 
*, P   0.05 by the Student’s t test, comparing mice treated with control 
and blocking Abs.  
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and inhibited the influx of new pDCs during the experiment
without affecting the numbers of LNDCs (Fig. 3 E) or the ex-
pression of CXCL9 and E-selectin on inflamed HEVs (Fig. S1
B). On day 7 after infection, mice treated with anti-Ly6G/C
Ab showed impaired CTL induction and function (Fig. 3, F
and G) and poor viral elimination (Fig. 3 H), compared with
control mice.
The third method used anti–pDC antigen (PDCA)-1
Ab, which is more specific for pDCs (16). Injecting mice
twice with 100 
 
 
 
g of anti–PDCA-1 Ab on days –1.5 and
0.5 depleted 
 
 
 
80% of PLN-resident pDCs (Fig. S1 C)
without affecting LNDCs. This protocol also inhibited the
increase in pDCs, but not LNDCs, in the PLNs (Fig. 3 I).
The number of IFN-
 
 
 
 
 
 CTLs and the CTL activity were
again reduced in anti–PDCA-1 Ab–treated mice, com-
pared with control mice (Fig. 3, J and K).
 
Impaired APC function of LNDCs in anti-Ly6G/C 
Ab–treated mice
 
We next investigated the stage at which CTL generation was
affected by the reduction in recruited pDCs in anti-Ly6G/C
mAb–treated mice. To distinguish the APC activities of dif-
ferent LN DC subtypes, we isolated them from HSV-infected
LNs and tested their abilities to stimulate IFN-
 
 
 
 production
by HSV-infected LN T cells in vitro
 
,
 
 without any further re-
stimulation. To our surprise, LN pDCs alone poorly induced
HSV-specific IFN-
 
 
 
 production (Fig. 4 A) by both CD4
 
 
 
 and
CD8
 
 
 
 T cells, indicating that they were not themselves acting
as APCs in vivo. In contrast, mDCs preferentially primed
HSV-specific CD4
 
 
 
 T cells, and CD8
 
 
 
 
 
 DCs selectively
primed HSV-specific CTLs (Fig. 4 A), which was consistent
with previous reports (6, 7). However, mDCs and CD8
 
 
 
 
 
DCs isolated from anti-Ly6G/C Ab–treated mice on day 2
failed to prime anti-HSV CD4
 
 
 
 or CD8
 
 
 
 T cells (Fig. 4 A).
LNDCs from anti-Ly6G/C Ab–treated mice did not
show reduced HSV uptake (5.3 
 
 
 
 1.1% in anti-Ly6G/C
Ab–treated mice vs. 5.9 
 
 
 
 1.4% in control mice, on cy-
tosmear preparations) or accumulation in LNs (Fig. 3 E).
To examine the ability of LNDCs to attract T cells, we
performed ex vivo clustering assays using B220
 
 
 
CD11c
 
 
 
LNDCs and CD3
 
 
 
 T cells isolated from PLNs from in-
fected mice. Cluster formation was significantly higher
with cells isolated from mice treated with control Ab,
compared with anti-Ly6G/C Ab (P 
 
 
 
 0.05; Fig. 4 B). As a
result, mDCs and CD8
 
   DCs from the anti-Ly6G/C Ab–
treated mice also failed to form clusters with T cells and to
induce IFN- –producing CD4  or CD8  T cells, respec-
tively (Fig. 4 A).
Figure 3. In vivo depletion of pDCs impairs CTL-mediated virus 
eradication. The effect of anti-CXCL9 and anti–E-selectin Abs on (A) the 
numbers of B220  LNDCs (mDCs and CD8   DCs) and B220  pDCs in 
PLNs after HSV infection, (B) the numbers of IFN-   spots produced by 
PLN CD8  T cells, (C) the specific lysis in vitro by PLN CD8  T cells, and (D) 
the virus titer in PLNs. The effect of anti-Ly6G/C Ab on (E) the numbers of 
B220  LNDCs (mDCs and CD8   DCs) and B220  pDCs in PLNs after HSV 
infection, (F) the numbers of IFN-   spots produced by PLN CD8  T cells, 
(G) the specific lysis in vitro by PLN CD8  T cells, and (H) the virus titer in 
PLNs. The effect of anti–PDCA-1 mAb on (I) the numbers of B220  LNDCs 
(mDCs and CD8   DCs) and B220  pDCs in PLNs after HSV infection, (J) 
the numbers of IFN-   spots produced by PLN CD8  T cells, and (K) the 
specific lysis in vitro by PLN CD8  T cells. Representative data from three 
independent experiments are presented as the mean   SD (n   6 or 
n   5 for anti–PDCA-1 mAb experiments. *, P   0.05 by Student’s 
t test, comparing mice treated with control and blocking Abs.JEM VOL. 202, August 1, 2005 429
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Reconstitution of anti-Ly6G/C Ab–treated mice with pDC 
precursors restores CTL induction by LNDCs in vivo
To find out whether the impaired CTL responses observed
in anti-Ly6G/C Ab–treated mice were actually dependent
on LN-recruited pDCs, we performed in vivo reconstitu-
tion assays by transferring blood pDC precursors i.v. into
HSV-infected, anti-Ly6G/C Ab–treated mice (Fig. 5 A).
We used freshly isolated blood pDC precursors because
maturing pDCs, restimulated in vitro, poorly enter LNs
when transferred (10). The donor pDC precursors were
characterized as nonantigen-pulsed, nonactivated cells (Fig.
1 B), which did not produce cytokines or chemokines un-
less they entered infected LNs (Fig. 1 D and Fig. 2 F).
Blood pDC precursors from Propionibacterium acnes–primed
mice were also used to see whether recruitment to LNs was
antigen-dependent or not.
In anti-Ly6G/C Ab–treated mice reconstituted with WT
pDC precursors, significant numbers of pDCs were recruited
to the paracortex of the PLNs (P   0.05; Fig. 5 B) and made
contact with DEC-205  LNDCs (Fig. 5 C) on day 2 of infec-
tion. Recruited pDCs were still detectable on day 4 of the in-
fection (48 h after transfer) and were associated with increased
numbers of BrdU CD4  T cells in the T cell zone (Fig. 5 D).
To investigate whether the function of LNDCs was restored,
LNDCs from reconstituted mice were tested for in vivo APC
activity and the ability to attract T cells. mDCs and CD8  
DCs isolated from reconstituted mice primed anti-HSV
CD4  or CD8  T cells (compare Fig. 5 E with Fig. 4A). The
ability of LNDCs to form clusters with T cells was also re-
stored (Fig. 5 F). On day 7, the functional CTL responses
were restored, and HSV was effectively eliminated after re-
constitution with blood pDC precursors (Fig. 5 G). Interest-
ingly, blood pDC precursors obtained from P. acnes–primed
mice could restore the host responses (Fig. 5, B, F, and G),
suggesting that pDC precursors could enter the inflamed LNs
in an antigen-independent manner but flexibly respond to an
antigen-bearing environment after entry.
In contrast, when anti-Ly6G/C Ab–treated mice were
reconstituted with blood pDC precursors from CXCR3–/–
mice, donor pDCs did not increase in the LNs (Fig. 5 B),
and neither LNDC function nor anti-HSV host responses
were restored (Fig. 5, E–G). These results demonstrated that
CXCR3-mediated recruitment of pDC precursors to LNs is
required to induce an anti-HSV CTL response in vivo.
LN-recruited pDCs restore CTL induction by impaired 
LNDCs in vitro
The ability of LN-recruited pDCs to restore the impaired
induction of anti-HSV CTLs by LNDCs was next examined
in co-culture experiments (Fig. 6 A). LN pDCs from mice
treated with control Ab (pDC) and LNDCs from anti-
Ly6G/C Ab–treated mice (impaired LNDC) on day 2 of in-
fection failed to induce anti-HSV CTLs in vitro (Fig. 6 B).
Because pDCs are major producers of cytokines (references
7, 15, 17, 18; Fig. 1 D), we tested the effect of several cyto-
kines on CTL induction by impaired LNDCs in this system.
However, adding IFN-  (Fig. 6 B) or other pDC cytokines,
including TNF- , IL-10, and IL-12 (unpublished data) was
not sufficient to restore the impaired LNDCs in co-culture.
In fact, co-culture with LN pDCs was essential to restore the
ability of impaired LNDCs to generate anti-HSV CTLs, and
this process was dose dependent (Fig. 6 C). In addition,
when pDCs and impaired LNDCs were co-cultured in sepa-
rate compartments of transwells, anti-HSV CTL activity was
not restored (Fig. 6 C), demonstrating that the help provided
by LN-recruited pDCs to completely activate anti-HSV
CTLs depends on cell–cell contact.
To investigate which molecules are involved in functional
recovery of impaired LNDCs in the presence of pDCs, we
set up a two-step co-culture system (Fig. 6 D). In step one,
impaired LNDCs and pDCs were co-cultured for 16 h. After
washing, LN CD8  T cells were added and co-cultured for a
further 48 h as step two. Impaired LNDC-mediated CTL in-
duction was restored in these culture conditions (Fig. 6 D,
left), indicating that the initial interaction with pDCs pro-
vided sufficient signals to activate LNDCs to induce CTLs.
When different blocking Abs were added during step one,
pDC-mediated recovery was not inhibited by anti-CD86,
-CD80, or -CD54 Abs (unpublished data), but was signifi-
cantly inhibited by anti-CD2 and -CD40L Abs (P   0.05;
Figure 4. Impaired APC function of LNDCs in pDC-depleted mice. 
(A) The number of IFN-   spots produced by CD4  or CD8  T cells 
obtained from control PLNs on day 2, after 16-h incubations with the 
indicated numbers of DCs with no in vitro restimulation. DCs alone formed 
no spots. (B) The percentage of cluster-forming LNDCs from uninfected 
mice (d0), HSV-infected, control Ab–treated mice on day 2, and HSV-infected, 
anti-Ly6G/C Ab–treated mice on day 2. Indicated LNDCs were incubated 
for 2 h with LN CD3  T cells from HSV-infected mice on day 2. T cells 
alone rarely formed clusters ( 5%) in all groups tested. Representative 
data from three independent experiments are presented as the mean   
SD (n   3). *, P   0.05 by Student’s t test, comparing mice treated with 
control or anti-Ly6C/G Ab.HELPER FUNCTION OF PDCs IN CTL RESPONSE | Yoneyama et al. 430
Fig. 6 D, middle). Although LN pDCs readily produce IFN- ,
even in short-term culture (Fig. 1 D), adding anti–IFN- 
Ab during step one did not affect the restoration of LNDC
function (Fig. 6 D, middle). However, when anti–IFN-  Ab
was added during step two, CTL activity was inhibited (Fig.
6 D, right). Moreover, pDCs from CD40L /  mice failed to
restore the function of LNDCs (Fig. 6 E). Collectively, these
results provide evidence that LNDC–pDC contact, involving
the CD2 and CD40L pathways, is initially required to restore
impaired LNDC function, and IFN-  promotes CTL prim-
ing by LNDCs, once the provision of pDC help has con-
verted their status from “impaired” into “recovered.”
DISCUSSION
Viruses, including HSV-1, can target DCs and disrupt the
antigen-presenting pathway at multiple levels, leading to
impairment of DC-mediated CTL immunity (1). Indeed,
HSV-infected hosts have both activated DCs, responsible
for T cell priming, and impaired DCs, showing reduced
transport of MHC–peptide complexes, T cell stimulatory
Figure 5. Reconstitution of pDC-depleted mice with pDC precursors 
restores CTL induction. (A) Donor precursor cells isolated from the 
peripheral blood of HSV-infected WT mice (WT pDC), HSV-infected CXCR3-
deficient mice (CXCR3 /  pDC), and P. acnes–primed WT mice (WT pDC 
[p.a.]) on day 2 were labeled with fluorescence dyes and adoptively trans-
ferred into HSV-infected, anti-Ly6G/C Ab–treated mice. LNDCs were iso-
lated from reconstituted mice on day 2 of infection, and LN CD8  T cells 
were isolated from reconstituted mice on day 7 of infection, for functional 
tests. The letters in parentheses correspond to panels in the figure. (B) Effective 
recruitment of WT, but not CXCR3 / , pDC precursors on day 2 of infection. 
(left and middle) Entry of CMTMR-labeled pDC precursors (orange) in the T 
cell zone (blue, CD3; green, B220) of PLN 2 h after cell transfer. Magnification, 
200. (right) The number of transferred pDCs observed in the T cell zone 
of PLN on day 2 of infection. Representative data from three independent 
experiments are presented as the mean   SD (n   3 for 15-mm2 sections). 
*, P   0.05 by the Student’s t test, comparing WT with CXCR3 /  pDCs. 
(C) CFSE-labeled WT pDC precursors (green) in contact with DEC-205  
(red) LNDCs in the T cell zone of PLN 2 h after cell transfer (day 2 of infection) 
at a magnification of 200. The inset shows a higher magnification (400). 
(D) CFSE-labeled WT pDC precursors in contact with BrdU  (red) and CD4  
(blue) T cells of PLN 48 h after cell transfer (day 4 of infection) at a 
magnification of 200. A higher magnification is indicated by the box 
(400). F, follicle; PC, paracortex; S, sinus. (E) The number of IFN-   spots 
produced by PLN CD4  or CD8  T cells (106 cells/well) from HSV-infected 
mice on day 2, after 16 h of incubation with LNDCs with no in vitro 
restimulation. LNDCs (mDCs or CD8   DCs; 105 cells/well) were obtained 
from anti-Ly6G/C mAb–treated mice reconstituted with WT pDC or CXCR3 /  
pDCs on day 2. DCs alone produced no spots. (F) The percentage of cluster-
forming LNDCs obtained from anti-Ly6G/C mAb–treated mice reconstituted 
with WT pDC, CXCR3 /  pDC, or WT pDC (p.a.) on day 2. Freshly isolated 
LNDCs were incubated with LN CD3  T cells from HSV-infected mice for 
2 h. (G) Specific lysis in vitro of PLN CD8  T cells and virus titers of PLNs 
obtained from pDC-depleted mice reconstituted with WT pDCs, CXCR3 /  
pDCs, or WT pDCs (p.a.) on day 7. Values for mice treated with control Ab 
(black dashed lines) and anti-Ly6G/C Ab (red dashed lines) on days 2 (F) 
and 7 (G) of infection are also shown to compare reconstituted mice with 
nonreconstituted mice as described in Figs. 3, G and H and Fig. 4 B. Repre-
sentative data from three independent experiments are presented as the 
mean   SD (n   3). *, P   0.05 by Student’s t test, comparing WT with 
CXCR3 /  pDCs.JEM VOL. 202, August 1, 2005 431
ARTICLE
capacity, and cytokine production (1, 19–22). Therefore,
the balance between the host DC networks and viruses,
that is, the balance between DC activation and impair-
ment, would determine the extent of antiviral host immu-
nity. The mechanisms that skew the DC network toward
activation are not completely understood but require the
host to mount functional CTL immunity and to prevent
viral escape. We have shown that pDCs contribute to the
activation of the LNDC network after migrating to in-
flamed LNs. Although pDCs do not directly prime anti-
HSV T cells, they help LNDCs to prime anti-HSV CTLs
by multiple mechanisms.
In response to local HSV-1 infection, pDC precursors
are rapidly mobilized into the circulation and recruited to
inflamed LNs (10). Here, pDCs up-regulate activation
markers and T cell–attracting chemokines, change the inte-
grins they express, and produce cytokines in response to en-
countering HSV. LN-recruited pDCs are retained for at least
48 h in the paracortex and associate with LNDCs. Thus,
pDCs actively participate in ongoing T cell responses by cre-
ating appropriate cytokine fields in their vicinity and attract-
ing immune cells by secreting chemokines. CXCR3 on
pDCs plays an important role in mediating both trans-HEV
migration (10) and DC–DC interactions in this model.
To inhibit the early, short-term accumulation of LN
pDCs (Fig. 1 A), we injected anti-CXCL9 and E-selectin
Abs or anti-Ly6G/C Ab at the time of HSV inoculation. LN
T cells isolated on day 2 from HSV-infected mice, treated
with either blocking Ab regime, could proliferate when
stimulated ex vivo with HSV-pulsed splenic DCs and mi-
grate to HSV-infected PLNs when adoptively transferred
(unpublished data). Although these findings suggested that
the blocking Abs affected LN pDCs selectively at an early
stage, we could not completely rule out the possibility that
the blocking Abs had a direct affect on activated T cells at a
later phase of infection. To rule this out, we performed in
vivo reconstitution assays. Taking advantages of CXCR3-
mediated trans-HEV migration of circulating pDC precur-
sors (10), we intravenously transferred 2   106 freshly iso-
lated blood pDC precursors per mouse, after treatment with
anti-Ly6G/C Ab (Fig. 5 A). This was a greater number of
blood pDC precursor cells than is present in an uninfected
mouse ( 104) or an HSV-infected mouse ( 1–3   105; ref-
erence 10). Because depletion of pDCs by anti-Ly6G/C Ab
treatment was incomplete, reducing the numbers by  70%,
as described above, it is possible that sufficient numbers of
adoptively transferred pDCs survived, even in the presence
of anti-Ly6G/C Ab in the circulation. We actually detected
Figure 6. CTL induction was restored using in vitro co-cultures 
with LN pDCs. (A) Diagram showing the protocol for co-culture experi-
ments. CTL activities were estimated after 48 h of co-culture. The letters in 
parentheses correspond to panels in the figure. Ctl LN, HSV-infected PLN 
treated with control Ab at day 2. (B) In vitro CTL activity induced by pDCs 
(purple line), LNDCs (pink line), and impaired LNDCs in the presence (orange 
line) or absence (green line) of rIFN- . (C) In vitro CTL activities induced by 
impaired LNDCs in the presence of pDCs, at ratios between 1:1 and 1:10, 
or with pDCs separated by transwells (red line, 1:1 ratio). (D, top) Diagram 
showing the protocol for two-step co-culture experiments. (top row) Step 
one, co-culture of impaired LNDCs and pDCs for 16 h. (bottom row) Addi-
tion of LN CD8  T cells for a further 48 h. (bottom) In vitro CTL activities 
induced by impaired LNDCs in the presence of equal numbers of pDCs, 
treated as indicated in the figure. Effector/target (E:T) ratio, 30:1. Repre-
sentative data from three independent experiments are presented as the 
mean   SD (n   3). *, P   0.05 by Student’s t test, comparing cells 
treated with control and blocking Abs. (E) in vitro CTL activities induced by 
impaired LNDCs in the presence of equal numbers of WT or CD40L /  
pDCs. E:T ratio, 30:1. Representative data from three independent experi-
ments are presented as the mean   SD (n   3).HELPER FUNCTION OF PDCs IN CTL RESPONSE | Yoneyama et al. 432
a significant (P   0.05) number of transferred pDCs in in-
flamed LNs (Fig. 5, B–D) from day 2 to 4 of infection, but
this temporal presence seems to be enough for these cells to
function, as accumulation of endogenous pDCs is also short-
term (Fig. 1 A) in this model. In addition, a complete anti-
HSV CTL response was mounted even in reconstituted,
anti-Ly6G/C Ab–treated mice (Fig. 5, F and G), ruling out
the possibility that this Ab directly affected activated CD8 
T cells. Furthermore, the impairment of the CTL response
in mice treated with anti–PDCA-1 Ab (Fig. 3, I–K),
strongly suggested that pDCs are required in anti-HSV,
CTL-mediated immunity.
One mechanism for the effect of pDCs may be the pro-
motion of DC–T cell clustering (Fig. 4 B and Fig. 5F). Re-
cent in vivo, real-time visualization techniques have pro-
vided new insights into DC–T cell interaction, showing
that there are short, weak, and multiple interactions over
approximately the first 8 h (23). It is timely to reevaluate the
signals that induce DCs to form stable and specific clusters
with T cells. We consider that pDCs deliver these signals to
LNDCs and that CD2 plays a role in this process because
LNDCs express some CD2 ligands (24). The formation of
CD2-mediated LNDC–pDC conjugates (Fig. 2 H) is linked
with the APC function of LNDCs for priming CTLs (Fig. 6
D). In this respect, in CD2-deficient mice, the induction of
anti–lymphocytic choriomeningitis virus CTLs has been re-
ported to require high doses of antigen (25, 26). It is possi-
ble that the extent of CD2’s in vivo effect varies, depending
on the type and dose of viral antigens. However, CD2 has
also been reported to be involved in T cell responses against
rare and cross-presented lymphocytic choriomeningitis vi-
rus antigens (25). In a cutaneous HSV-1 infection model, it
is now clear that HSV-1 antigens are cross-presented to T
cells (6). Thus, we consider that CD2 plays a significant role
in cross-priming anti-HSV CTLs.
The role of CD40L on pDCs is of interest for licensing
LNDCs to prime CTL immunity. Previous studies have
suggested that CD40L on activated CD4  T cells generally
provides this signal to DCs (2, 27). However, in a primary
immune response, CD4  T cells first need to be activated
by antigen-primed mDCs (5, 14), and it is not clear how
mDCs initially receive these signals before activated CD4 
T cells appear. We have shown that LN-recruited pDCs
rapidly express cell surface CD40L (Fig. 1 C and Fig. 2 G).
Although the CD40L  pDCs were only 6.3% of the total
LN pDCs, this was relatively high when compared with
the CD40L CD4  T cells, which constitute only 0.28% of
LN T cells (unpublished data) on day 2 of infection. We
believe that the activated pDCs recruited to LNs rapidly
provide the initial CD40L signals to LNDCs, to promote
their ability to present antigen to both CD4  and CD8  T
cells. This interaction of CD40L and CD40 on DCs in-
volves cell–cell contact and leads to the translocation of
lipid rafts, aggregation of MHC class II and CD80 to en-
hance antigen presentation (28), activation of TRAF6 to
prime antigen-specific CD4  T cells (29), up-regulation of
transporter associated with antigen processing to augment
antigen processing (30), and the promotion of cross-pre-
sentation on MHC class I to CD8  T cells (31).
Recent experiments have revealed that pDCs are potent
producers of cytokines and chemokines in inflammation (7).
IFN- , in particular, plays an important role by not only
preventing viral replication and spread, but also by stimulat-
ing DCs and NK cells. In DC-mediated viral immunity,
IFN-  has been shown to promote the cross-priming of
CTLs (32) and activate uninfected, bystander DCs (21), de-
pending on the dose and timing. In contrast, in our culture
conditions, impaired LNDCs failed to completely mature to
induce CTLs, even in the presence of IFN-  (Fig. 6 A).
However, DCs used in previous studies were “conven-
tional” DCs, which are distinct from the virally impaired
DCs used in this study (Fig. 6). We propose that pDCs help
LNDCs in at least two steps: first, pDCs contact impaired
LNDCs through CD2–CD2L interactions, and engagement
of the CD40L–CD40 interaction sets the LNDCs into a re-
covered condition; and second, recovered LNDCs can now
prime T cells using the appropriate signals, such as IFN- .
Inhibiting IFN-  reduced the ability of LNDCs to induce
CTLs only after the LNDCs received help from pDCs (Fig.
6 D), indicating that IFN-  can stimulate only recovered/
conventional LNDCs to prime CTLs, which is consistent
with previous studies (21, 32). When we tested the in vivo
effect of IFN-  by injecting locally into anti-Ly6G/
C–treated mice at the time of infection, there was a slight
recovery of CTL numbers (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20041961/DC1) with
undefined mechanism. However, recovered LNDCs need
additional IFN-  signals to prime T cells at the second stage
(Fig. 6 D). Because pDCs were not completely depleted by
anti-Ly6G/C Ab, it is plausible to speculate that the residual
activity of remaining pDCs might have been compensated
by exogenous IFN-  at the second stage.
Our observations demonstrate a novel role for LN-
recruited pDCs as “immune networkers” in antiviral CTL
immunity, in addition to their known function as a source of
IFN- . Although distinct subsets of DCs can induce the cor-
responding effector T cells ex vivo (2, 5, 6), in vivo LNDC–T
cell networks are more interactive, both temporally and
spatially. The creation of appropriate cytokine fields and the
mediation of cell communication by pDC-derived cyto-
kines, and chemokines are essential to antiviral host defense.
Viral escape creates a major problem in immunotherapy, and
some viruses evade immune surveillance even in hosts vacci-
nated with antigen-primed DCs or CTLs generated ex vivo
(4, 24). DC dysfunction is also seen in cancer patients and is
a major factor impairing the generation of anti-tumor CTLs
(4, 24). Our study suggests the potent ability of pDCs to im-
prove the activity and communication of impaired DC net-
works and may provide a novel strategy for the development
of DC-based vaccination, to improve CTL induction against
persistent viral infection, such as hepatitis and AIDS, and also
in cancer.JEM VOL. 202, August 1, 2005 433
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MATERIALS AND METHODS
Mice. Specific pathogen-free mice were used in all experiments. Female
C57BL/6 mice (8–9-wk old) were obtained from CLEA Japan Inc.
CXCR3-deficient mice were generated as previously reported (33) and
backcrossed into C57BL/6 mice for eight generations. B6 background
CD40L-deficient mice (provided by R. Abe, Tokyo University of Science,
Tokyo, Japan) were bred as previously reported (34). All animal experi-
ments complied with the guidelines set by the University of Tokyo Gradu-
ate School of Medicine.
HSV-1 and P. acnes infection. The KOS strain of HSV-1 (provided by
T. Kaburaki, University of Tokyo, Tokyo, Japan) was propagated and ti-
tered using Vero cells grown in MEM with 10% FCS. Mice were infected
with 5   104 PFU in the right hind foot, and the right PLNs were re-
moved for examination at the times indicated in the figures. Virus titers
were determined on day 7 in standard serial dilution plaque assays. Mice
were infected with heat-killed P. acnes (1 mg/100  l PBS; 11828; Ameri-
can Type Culture Collection) via tail vein injections (9–11, 14). In some
experiments, mice were injected with BrdU (500  g/100  l PBS; Sigma-
Aldrich) 1 h before death (9, 14).
Cell sorting and culture and flow cytometry. DC and T cell popu-
lations were isolated using a cell sorter (EPICS ELITE ESP; Beckman
Coulter) or a MACS system (Miltenyi Biotech) as previously described
(9–11, 14). For cell sorting, MHCII-, CD19-, CD3-, and DX5-
depleted blood cells or CD19-, CD3-, and DX5-depleted LN cells were
stained with anti-CD11c–FITC mAb and anti-B220–PE mAb (BD Bio-
sciences). Analysis of the sorted populations showed purities  95%. For
DC phenotyping, blood and LN cells were stained with biotinylated
mAbs against CD2, CD40, CD40L, CD86 (BD PharMingen), and Cy-
Chrome–conjugated streptavidin, followed by incubation with anti-
CD11c–FITC mAb and anti-B220–PE mAb.
Purified B220 CD11c  cells (105 cells/200- l well) were incubated
for 16 h in round bottom 96-well culture plates in RPMI 1640 with 20%
FCS, 100 U/ml penicillin G, and 100  /ml streptomycin in the presence or
absence of irradiated HSV (30 PFU/well). IFN-  (PBL-Biomedical) in the
culture supernatants was assayed using an ELISA (10).
pDC depletion and reconstitution experiments. To inhibit pDC pre-
cursor recruitment to LNs, mice were injected i.v. with 100  g anti-CXCL9
(R&D Systems) plus E-selectin (10) or control (goat IgG; Sigma-Aldrich) Abs
immediately before HSV infection. To deplete the pDC fractions, mice were
injected i.p. with 200  g anti-Ly6G/C mAb (clone RB6-8C5; BD Bio-
sciences), 100  g of anti–PDCA-1 mAb (clone JF05-1C2.4.1, functional
grade; Miltenyi Biotec), or control Ab (rat IgG; Sigma-Aldrich) 1.5 d before
and 0.5 d after infection (Fig. 3 and Fig. S1 C).
For short-term reconstitution assays, 2   106 blood pDC precursors,
collected on day 2 from HSV-infected WT or CXCR3 /  mice or from
P. acnes–primed mice, were injected i.v. on day 1.5 into anti-Ly6G/C
Ab–treated mice infected with HSV. pDC-reconstituted mice were
killed 0.5, 1.5, and 5.5 d later (Fig. 5 A). Before cell transfer, 90–92%
pure MACS-sorted pDCs were labeled with 2.5  M CFSE (Molecular
Probes) for 10 min at 37 C or with 5  M 5-(and-6)-([(4-chloro-
methyl)benzoyl]amino) tetramethylrhodamine (CMTMR; Molecular
Probes) for 15 min at 37 C (9, 10).
Antibodies and immunohistochemistry. Immunohistochemical stain-
ing was performed as previously reported (9, 14). The following anti–
mouse mAbs were used: CD2 (clone RM2-5), CD3  (145-2C11), CD4
(RM4-5), CD8  (53-6.7), CD11c (HL3), CD19 (1D3), CD40 (HM40-3),
CD45R/B220 (RA3-6B2), CD86 (GL1), CD154/CD40L (MR1) and
Pan–NK cell (DX5; all from BD Biosciences), DEC-205 (BMA), and
CD11c (N418; Serotec). Rabbit pAb to CCL21 was made in house (9). As
secondary Abs, we used Alexa 488–labeled anti–rat Ig, Alexa 564–labeled
anti–hamster, rabbit, and rat Igs, Alexa 647–labeled anti–rat Ig, and strep-
toavidin labeled with Alexa 564 or 647 (Molecular Probes). For control
Abs, we used rat IgG, rabbit IgG, and hamster IgG (Sigma-Aldrich).
ELISPOT assay. Nitrocellulose 96-well plates (Millipore) were coated
with 2  g/ml of purified anti–IFN-  mAb (clone R4-6A2; BD Bio-
sciences) overnight at 4 C and washed five times in RPMI 1640 with 10%
FCS. For CTL precursor frequency assays (Fig. 3, B, F, and J), 92–96% pure
MACS-isolated CD8  T cells obtained from HSV-infected PLN on day 7
were plated at 106 cells/well in the presence or absence of irradiated HSV
(30 PFU/well). For ex vivo APC assays (Fig. 4 A and Fig. 5 E), MACS-iso-
lated CD4  or CD8  T cells obtained from HSV-infected PLN on day 2
were plated at 106 cells/well without restimulation by exogenous antigens.
The indicated numbers of sorted DC populations (mDCs, CD8   DCs,
and pDCs) from HSV-infected PLN on day 2 were separately added, in
triplicate, to the wells in 100- l aliquots. After overnight incubation at
37 C, the plates were washed eight times with 0.05% Tween–PBS and in-
cubated with 2  g/ml of biotinylated anti–IFN-  mAb (clone XMG1.2;
BD Biosciences) for 2 h, followed by streptavidin–horseradish peroxidase
conjugate (Zymed Laboratories) for 2 h and aminoethyl carbazole substrate
(Vector Laboratories). The red spots were counted using a dissecting micro-
scope (SZX9; Olympus). In CTL precursor frequency assays, no spots were
detected when CD8  T cells were cultured in the absence of HSV.
Cluster formation assay. An ex vivo cluster formation assay was per-
formed as described previously (35), with slight modifications. For DC–T
cell clusters (Fig. 4 B and Fig. 5 F), 105 MACS-separated B220  LNDCs
from the indicated mice and 106 MACS-separated CD3  T cells from the
PLNs of HSV-infected mice at day 2 were co-cultured for 2 h in 500  l of
medium, rotating at 40 rpm at 37 C. For LNDC–pDC conjugates (Fig. 2,
G and H), 5   104 MACS-separated B220  LNDCs and 5   104 pDCs
from the PLNs of uninfected or HSV-infected mice at day 2 were incu-
bated for 2 h in 500  l of medium, rotating at 40 rpm at 37 C with anti-
CD2, anti-CD2 plus CXCL10, or 100  g/ml of control Abs. Cluster for-
mation was estimated by directly counting 1,000 free and clustered LNDCs
on cytosmear preparations. In DC–T cell clusters, an LNDC cluster was
judged as three or more T cells. In DC–DC conjugates, an LNDC conju-
gate was judged as containing one or more B220  pDCs after immuno-
staining for B220. In some experiments, MACS-sorted LNDCs or pDCs
were prelabeled with 10 or 2.5  m CFSE, respectively, to determine the
distribution of CD40L (Fig. 2 G). Clustered LNDCs were expressed as a
percentage of the total number of cells counted.
CTL assay. To investigate DC-mediated CTL activity (Fig. 6, A–C), 106
PLN CD8  T cells, obtained from HSV-infected mice on day 2, were co-
cultured with 105 mitomycin C–treated d2 DCs of the indicated subsets for
48 h without any restimulation in vitro. Four sets of culture experiments
were performed using (a) LNDCs from anti-Ly6G/C Ab–treated mice (im-
paired LNDC) supplemented with or without 1,000 U/ml of recombinant
IFN-  (Hycult Biotechnology); (b) impaired LNDCs plus pDCs at ratios of
1:1, 3:1, and 10:1; (c) LNDCs from control Ab–treated mice; and (d) pDCs
from control Ab–treated mice. To exclude the T cell–derived factors, a
two-step co-culture system was also set up (Fig. 6 D). Equal numbers (105)
of impaired LNDCs and pDCs were co-cultured for 16 h, supplemented
with a neutralizing anti–IFN-  (Hycult Biotechnology), anti-CD2, anti-
CD40L mAb, or 100  g/ml of control Abs. After washing, these DCs were
co-cultured for a further 48h with 106 PLN CD8  T cells obtained from
HSV-infected mice on day 2. Cytotoxicity was measured in standard 4-h
LDH release assays using a Cytotoxicity Detection Kit (Boehringer) as de-
scribed previously (11, 36). Specific cytotoxicity was determined using
HSV-infected splenocytes as target cells and calculated relative to LDH re-
lease in medium alone. In some experiments (Fig. 6 E), we used pDCs from
HSV-infected, CD40L-deficient mice. Because CD40L /  mice show re-
duced number of LN cells as reported (37), we pooled right inguinal,
popliteal, and lumbar LNs to collect a sufficient number of cells. To investi-
gate whether CTLs were generated in vivo (Figs. 3, C, G, and K and Fig.HELPER FUNCTION OF PDCs IN CTL RESPONSE | Yoneyama et al. 434
5G), 106 PLN CD8  T cells obtained from HSV-infected mice on day 7
(and day 0 for negative control) were tested without adding DCs.
Online supplemental material. Fig. S1 provides data for the effect of
anti-Ly6G/C Ab (A and B) and anti–PDCA-1 (C) on the percentage of
PLN pDCs. Fig. S2 shows the in vivo effect of recombinant IFN-  on anti-
HSV CTL generation in anti-Ly6G/C Ab–treated mice. Online supple-
mental material is available at http://www.jem.org/cgi/content/full/
jem.20041961/DC1.
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